1. Sigilon Therapeutics Appoints Veteran Biotech Industry Leader John Cox to Board of Directors

    Sigilon Therapeutics Appoints Veteran Biotech Industry Leader John Cox to Board of Directors

    Sigilon Therapeutics, a biopharmaceutical company creating functional cures for chronic diseases using Shielded Living Therapeutics™, today announced the appointment of distinguished biopharma executive John Cox, MBA, to its Board of Directors. Mr. Cox has over 25 years of experience in biopharmaceuticals, most notably in his former role as Chief Executive Officer of Bioverativ. In that role, Mr. Cox built, grew and led the company to an $11.6 billion acquisition by Sanofi, which was considered one of the most successful spinouts in biopharma history...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned